Effects of statins on progression of coronary artery disease as measured by intravascular ultrasound (Q33962454)

30 July 2017

0 references

Effects of statins on progression of coronary artery disease as measured by intravascular ultrasound (English)

1 reference

30 July 2017

main subject

coronary artery disease

1 reference

Updesh Bedi

1

1 reference

30 July 2017

Mukesh Singh

2

1 reference

30 July 2017

Param Singh

3

1 reference

30 July 2017

Janos Molnar

4

1 reference

30 July 2017

Sandeep Khosla

5

1 reference

30 July 2017

Rohit Arora

6

1 reference

30 July 2017

publication date

16 February 2011

1 reference

Journal of Clinical Hypertension

30 July 2017

published in

1 reference

30 July 2017

volume

13

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

492-496

1 reference

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Intravascular ultrasound: novel pathophysiological insights and current clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Serial intravascular ultrasound evidence of both plaque stabilization and lesion progression in patients with ruptured coronary plaques: effects of statin therapy on ruptured coronary plaque.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00428.X

10.1111/J.1751-7176.2011.00428.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference